Axil Brands vs Bioharvest Sciences
Bioharvest Sciences reported revenue of $34 million in fiscal 2025, about the same as Axil Brands' $31 million in fiscal 2026. Axil Brands' revenue grew 17.5% in its latest year, and Bioharvest Sciences' grew 37.0%. Axil Brands had an operating margin of 9.7%, against -16.2% at Bioharvest Sciences. Free cash flow was −$0 million at Axil Brands and −$10 million at Bioharvest Sciences. Their fiscal years end in different months (May 31 and December 31), so the periods don't line up exactly.
Side by side
| Axil Brands | Bioharvest Sciences | |
|---|---|---|
| Latest fiscal year | FY2026, May 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $31M | $34M |
| Revenue growth | 17.5% | 37.0% |
| Revenue growth a year, last 5 years | 80.7% | — |
| Gross margin | 69.3% | 59.3% |
| Operating margin | 9.7% | −16.2% |
| Net margin | 8.8% | −32.3% |
| Free cash flow | −$0M | −$10M |
| Free cash flow margin | −0.3% | −27.8% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 0.5% | — |
| Last close | $4.50 | $1.32 |
| P/E at the last close | 13.2× | — |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Axil BrandsBioharvest Sciences
Operating margin
Percent of revenue
Axil BrandsBioharvest Sciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Axil BrandsBioharvest Sciences
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Axil Brands and Bioharvest Sciences pages.